Nipro Corp

5FA

Company Profile

  • Business description

    Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

  • Contact

    3-9-3 Honjo-Nishi Kita-ku
    Osaka531-8510
    JPN

    T: +81 663722331

    http://www.nipro.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 March 2026

    Employees

    40,590

Stocks News & Analysis

stocks

How I lost all my savings through a poor investment decision

With first timers at risk of poor investment decisions and an interest in speculative stocks, I explore my biggest investing mistake.
stocks

Our view of Nvidia / OpenAI deal

Big AI dreams as firms announce a strategic partnership.
stocks

Chart of the Week: Morningstar’s forecast for CSL’s future

We see gross margin expansion on efficiencies and limited tariff impact

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,070.5041.000.45%
CAC 407,827.4544.57-0.57%
DAX 4023,666.8155.480.23%
Dow JONES (US)46,121.28171.50-0.37%
FTSE 1009,250.4327.110.29%
HKSE26,605.3386.680.33%
NASDAQ22,497.8675.62-0.33%
Nikkei 22545,698.4868.170.15%
NZX 50 Index13,123.6757.64-0.44%
S&P 5006,637.9718.95-0.28%
S&P/ASX 2008,778.7040.800.47%
SSE Composite Index3,859.625.980.16%

Market Movers